UroGen Pharma Ltd. (URGN) Insider Trading
Directors, officers and holders of more than 10% of URGN report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 125 transactions on file: 0 with code P, 14 with code S and 36 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 8, 2026 | Degnan Chris | Chief Financial Officer | S Sale | 2,202 | $36.69 | $80,791 |
| Oct 8, 2026 | Degnan Chris | Chief Financial Officer | M Exercise | 4,483 | Not measured | Not measured |
| Oct 8, 2026 | Degnan Chris | Chief Financial Officer | M Exercise | 4,483 | Not measured | Not measured |
| Sep 8, 2026 | Schoenberg Mark | Chief Medical Officer | S Sale | 871 | $42.92 | $37,383 |
| Sep 8, 2026 | Smith Jason Drew | General Counsel | S Sale | 1,519 | $42.54 | $64,618 |
| Sep 7, 2026 | Smith Jason Drew | General Counsel | M Exercise | 3,334 | Not measured | Not measured |
| Sep 7, 2026 | Schoenberg Mark | Chief Medical Officer | M Exercise | 1,667 | Not measured | Not measured |
| Sep 7, 2026 | Schoenberg Mark | Chief Medical Officer | M Exercise | 1,667 | Not measured | Not measured |
| Sep 7, 2026 | Smith Jason Drew | General Counsel | M Exercise | 3,334 | Not measured | Not measured |
| Aug 26, 2026 | Robinson James A. Jr. | Director | M Exercise | 2,000 | Not measured | Not measured |
| Aug 26, 2026 | Robinson James A. Jr. | Director | M Exercise | 2,000 | Not measured | Not measured |
| Aug 20, 2026 | Schoenberg Mark | Chief Medical Officer | S Sale | 60,677 | $47.05 | $2,854,853 |
| Jul 9, 2026 | Schoenberg Mark | Chief Medical Officer | S Sale | 10,000 | $40.00 | $400,000 |
| Jun 22, 2026 | Wildman Daniel George | Director | A Award | 10,000 | Not measured | Not measured |
| Jun 22, 2026 | Wildman Daniel George | Director | A Award | 8,000 | Not measured | Not measured |
| Jun 22, 2026 | Robinson James A. Jr. | Director | A Award | 8,000 | Not measured | Not measured |
| Jun 22, 2026 | Robinson James A. Jr. | Director | A Award | 10,000 | Not measured | Not measured |
| Jun 22, 2026 | Belldegrun Arie | Director | A Award | 20,000 | Not measured | Not measured |
| Jun 22, 2026 | WEN LEANA | Director | A Award | 10,000 | Not measured | Not measured |
| Jun 22, 2026 | WEN LEANA | Director | A Award | 8,000 | Not measured | Not measured |
| Jun 22, 2026 | BUTITTA CYNTHIA M | Director | A Award | 8,000 | Not measured | Not measured |
| Jun 22, 2026 | BUTITTA CYNTHIA M | Director | A Award | 10,000 | Not measured | Not measured |
| Jun 22, 2026 | Schoenberg Mark | Chief Medical Officer | S Sale | 10,000 | $35.01 | $350,100 |
| Jun 22, 2026 | Holden Stuart | Director | A Award | 20,000 | Not measured | Not measured |
| Jun 8, 2026 | Schoenberg Mark | Chief Medical Officer | M Exercise | 10,000 | Not measured | Not measured |
| Jun 8, 2026 | Schoenberg Mark | Chief Medical Officer | S Sale | 5,222 | $27.30 | $142,561 |
| Jun 8, 2026 | Schoenberg Mark | Chief Medical Officer | M Exercise | 10,000 | Not measured | Not measured |
| May 26, 2026 | Robinson James A. Jr. | Director | M Exercise | 2,000 | Not measured | Not measured |
| May 26, 2026 | Robinson James A. Jr. | Director | M Exercise | 2,000 | Not measured | Not measured |
| May 8, 2026 | Schoenberg Mark | Chief Medical Officer | S Sale | 10,000 | $30.00 | $300,000 |
| Feb 3, 2026 | Schoenberg Mark | Chief Medical Officer | S Sale | 3,686 | $19.69 | $72,577 |
| Feb 3, 2026 | Schoenberg Mark | Chief Medical Officer | S Sale | 1,843 | $19.69 | $36,289 |
| Feb 3, 2026 | Schoenberg Mark | Chief Medical Officer | S Sale | 1,844 | $19.69 | $36,308 |
| Feb 3, 2026 | Smith Jason Drew | General Counsel | S Sale | 3,217 | $19.69 | $63,343 |
| Feb 3, 2026 | Smith Jason Drew | General Counsel | S Sale | 1,608 | $19.69 | $31,662 |
| Feb 3, 2026 | Smith Jason Drew | General Counsel | S Sale | 2,654 | $19.69 | $52,257 |
| Jan 31, 2026 | Schoenberg Mark | Chief Medical Officer | M Exercise | 3,334 | Not measured | Not measured |
| Jan 31, 2026 | Schoenberg Mark | Chief Medical Officer | M Exercise | 3,334 | Not measured | Not measured |
| Jan 31, 2026 | Schoenberg Mark | Chief Medical Officer | M Exercise | 6,666 | Not measured | Not measured |
| Jan 31, 2026 | Schoenberg Mark | Chief Medical Officer | A Award | 20,000 | Not measured | Not measured |
| Jan 31, 2026 | Schoenberg Mark | Chief Medical Officer | M Exercise | 3,333 | Not measured | Not measured |
| Jan 31, 2026 | Schoenberg Mark | Chief Medical Officer | M Exercise | 6,666 | Not measured | Not measured |
| Jan 31, 2026 | Degnan Chris | Chief Financial Officer | A Award | 32,609 | Not measured | Not measured |
| Jan 31, 2026 | Barrett Elizabeth A. | Chief Executive Officer | A Award | 153,195 | Not measured | Not measured |
| Jan 31, 2026 | Smith Jason Drew | General Counsel | M Exercise | 5,500 | Not measured | Not measured |
| Jan 31, 2026 | Smith Jason Drew | General Counsel | M Exercise | 6,667 | Not measured | Not measured |
| Jan 31, 2026 | Smith Jason Drew | General Counsel | M Exercise | 3,333 | Not measured | Not measured |
| Jan 31, 2026 | Smith Jason Drew | General Counsel | M Exercise | 5,500 | Not measured | Not measured |
| Jan 31, 2026 | Schoenberg Mark | Chief Medical Officer | M Exercise | 3,333 | Not measured | Not measured |
| Jan 31, 2026 | Smith Jason Drew | General Counsel | M Exercise | 3,333 | Not measured | Not measured |
The full Form 4 history is on the URGN company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.